The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Rhabdomyosarcoma: An Overview
Open accessAbstract
Rhabdomyosarcoma (RMS) is a malignant tumor of mesenchymal origin thought to arise from cells committed to a skeletal muscle lineage. With approximately 250 cases diagnosed yearly in the United States, it is the third most common extracranial solid tumor of childhood after Wilms' tumor and neuroblastoma. Important epidemiologic, biologic, and therapeutic differences have been elucidated within the RMS family. Common sites of primary disease include the head and neck region, genitourinary tract, and extremities. A site-based tumor-nodes-metastasis staging system is being incorporated into use for assessing prognosis and assigning therapy in conjunction with the traditional surgicopathologic clinical grouping system. The development of intensive multimodality treatment protocols tested in large-scale international trials has resulted in significant improvements in outcome, especially for patients with local or locally extensive disease for whom a 60%-70% disease-free survival can be expected. Despite aggressive approaches incorporating surgery, dose-intensive combination chemotherapy, and radiation therapy, the outcome for patients with metastatic disease remains poor. Future challenges include the development of less toxic therapy for patients with localized disease and new approaches for patients with metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,027
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Perez-Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,404
The Third Intergroup Rhabdomyosarcoma Study.
Crist, W., Gehan, E. A., Ragab, A. H., Dickman, P. S., Donaldson, S. S., Fryer, C., Hammond, D., Hays, D. M., Herrmann, J., & Heyn, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.610 · Cited by 999
Principles and Practice of Pediatric Oncology
Labotka, R. J. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540480082049 · Cited by 630
Cancer incidence, survival, and mortality for children younger than age 15 years
Young, J. L., Ries, L. G., Silverberg, E., Horm, J. W., & Miller, R. W. (1986) · Cancer · doi:10.1002/1097-0142(19860715)58:2+<598::aid-cncr2820581332>3.0.co;2-c · Cited by 571
Oncogenes in solid human tumours
Pulciani, S., Santos, E., Lauver, A. V., Long, L. K., Aaronson, S. A., & Barbacid, M. (1982) · Nature · doi:10.1038/300539a0 · Cited by 478
Microsatellite alterations as clonal markers for the detection of human cancer.
Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F., & Sidransky, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9871 · Cited by 447
Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R., & Naeve, C. W. (1993) · PubMed · Cited by 383
Borgström, P., Hillan, K. J., Sriramarao, P., & Ferrara, N. (1996) · PubMed · Cited by 331
Miser, J. S., Kinsella, T. J., Triche, T. J., Tsokos, M., Jarosinski, P., Forquer, R., Wesley, R., & Magrath, I. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1191 · Cited by 317
Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping
Scrable, H. J., Witte, D. P., Lampkin, B. C., & Cavenee, W. K. (1987) · Nature · doi:10.1038/329645a0 · Cited by 263
El‐Badry, O. M., Minniti, C. P., Kohn, E. C., Houghton, P. J., Daughaday, W. H., & Helman, L. J. (1990) · PubMed · Cited by 249
Self-citationConsistent chromosomal translocation in alveolar rhabdomyosarcoma
Turc-Carel, C., Lizard-Nacol, S., Justrabo, E., Favrot, M., Philip, T., & Tabone, E. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90069-5 · Cited by 228
Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.
Diller, L., Sexsmith, E., Gottlieb, A., Li, F. P., & Malkin, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117834 · Cited by 220
Zhan, S., Shapiro, D. N., & Helman, L. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117344 · Cited by 217
Self-citationCommon and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly, K. M., Womer, R. B., Sorensen, P. H., Xiong, Q. B., & Barr, F. G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1831 · Cited by 203
Heyn, R., Haeberlen, V, Newton, W. A., Ragab, A. H., Raney, R. B., Tefft, M., Wharam, M., Ensign, L. G., & Maurer, H. M. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.2.262 · Cited by 192
Kalebic, T., Tsokos, M., & Helman, L. J. (1994) · PubMed · Cited by 189
Self-citationLawrence, W., Gehan, E. A., Hays, D. M., Beltangady, M., & Maurer, H. M. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.46 · Cited by 188
Horowitz, M. E., Kinsella, T. J., Wexler, L. H., Belasco, J., Triche, T., Tsokos, M., Steinberg, S. M., McClure, L., Longo, D. L., & Steis, R. G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1911 · Cited by 167
Dias, P., Parham, D. M., Shapiro, D. N., Webber, B. L., & Houghton, P. J. (1990) · Europe PMC (PubMed Central) · Cited by 144
Incidence of Childhood Cancer: Experience of a Decade in a Population-Based Registry 2
Shira Kramer, P. D. 4., Meadows, A. T., Patricia Jarrett, B. A., & Audrey E. Evans, M. D. (1983) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/70.1.49 · Cited by 127
Ferracini, R., Olivero, M., Renzo, M. F. D., Martano, M., Giovanni, C. D., Nanni, P., Basso, G., Scotlandi, K., Lollini, P., & Comoglio, P. M. (1996) · PubMed · Cited by 122
Tonin, P. N., Scrable, H. J., Shimada, H., & Cavenee, W. K. (1991) · PubMed · Cited by 121
Kościelniak, E., Klingebiel, T., Peters, C., Hermann, J., Burdach, S. E. G., Bender-Götze, C., Müller-Weihrich, S., & Treuner, J. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700628 · Cited by 94
Pappo, A. S., Shapiro, D. N., & Crist, W. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70539-3 · Cited by 91
Koscielniak, E., Rodary, C., Flamant, F., Carli, M., Treuner, J., Pinkerton, C. R., & Grotto, P. (1992) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950200305 · Cited by 83
Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications
Morison, I. M., & Reeve, A. E. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01197-0 · Cited by 67
Molecular genetics of Beckwith-Wiedemann syndrome
Li, M., Squire, J. A., & Weksberg, R. (1997) · Current Opinion in Pediatrics · doi:10.1097/00008480-199712000-00012 · Cited by 66
Raney, B., Ensign, L. G., Foreman, J. T., Khan, F., Newton, W. A., Ortega, J., Ragab, A. H., Wharam, M. D., Wiener, E. S., & Maurer, H. M. (1994) · PubMed · Cited by 56
N‐ras gene activation in the rd human rhabdomyosarcoma cell line
Chardin, P., Yeramian, P., Madaule, P., & Tavitian, A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350513 · Cited by 43
Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors
Lawrence, W., Hays, D. M., Heyn, R. M., Beltangady, M. S., & Maurer, H. M. (1988) · World Journal of Surgery · doi:10.1007/bf01655884 · Cited by 37
Pappo, A. S., Bowman, L. C., Furman, W. L., Rao, B. N., Kun, L. E., Jenkins, J. J., Crom, W. R., Luo, X., Kaste, S. C., Avery, L., et al. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00006 · Cited by 28
Frascella, E., Pritchard‐Jones, K., Modak, S. I., Mancini, A., Carli, M., & Pinkerton, R. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00665-6 · Cited by 26
(1993) · doi:10.1002/1097-0142(19930301)71:5<1904::aid-cncr2820710530>3.0.co;2-x
(1988) · doi:10.1002/1097-0142(19881001)62:7<1257::aid-cncr2820620703>3.0.co;2-k
Cited by
Making muscle: skeletal myogenesis in vivo and in vitro
Chal, J., & Pourquié, O. (2017) · Development · doi:10.1242/dev.151035 · Cited by 825
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
Wan, X., Harkavy, B., Shen, N., Grohar, P., & Helman, L. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209990 · Cited by 755
Self-citationYu, Y., Khan, J., Khanna, C., Helman, L., Meltzer, P. S., & Merlino, G. (2004) · Nature Medicine · doi:10.1038/nm966 · Cited by 525
Self-citationTrends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005
Ognjanovic, S., Linabery, A. M., Charbonneau, B., & Ross, J. A. (2009) · Cancer · doi:10.1002/cncr.24465 · Cited by 497
Malempati, S., & Hawkins, D. S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24118 · Cited by 422
Metadata
- Authors
- Dagher, R., & Helman, L.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02-01
- Volume
- 4
- Issue
- 1
- Pages
- 34-44
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2100950671
- Cited by
- 382
- References
- 37
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.